| Filed | Description | |
|---|---|---|
| 9/22/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 11/19/24 | 1.01 Material Agreement | → |
| 5/22/24 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 12/8/22 | 1.01 Material Agreement | → |
| 7/6/22 | 1.012.03 Material Agreement · New Debt Obligation | → |
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.